» Articles » PMID: 24434015

[Cardiovascular Involvement in Behçet's Disease]

Overview
Journal Rev Med Interne
Publisher Elsevier
Specialty General Medicine
Date 2014 Jan 18
PMID 24434015
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular involvement is a common complication of Behçet's disease (BD) and affects up to 40% of BD patients. These complications worsen the prognosis of BD. The concept of vasculo-Behçet has been adopted for cases in which vascular complications dominate the clinical features. Vascular manifestations affect particularly young men, during the first years following onset of the disease. Venous complications are the most frequent vascular complications, affecting 14 to 40% of BD patients. Superficial and deep lower limb thrombosis is the most frequent venous complications but one third of venous thrombosis concern large vessels (such as cerebral venous thrombosis, pulmonary embolism, and inferior or superior vena cava, etc.). Budd-Chiari syndrome is the worst prognostic factor increasing mortality by 9 times. Arterial complications (2 to 17% of BD patients) include aneurysms and occlusions/stenosis. Main locations of arterial lesions are aortic (abdominal and thoracic), femoral, pulmonary and iliac arteries. Aneurysms are the most severe arterial complications, particularly pulmonary aneurysms associated with a high risk of massive bleeding. Cardiac complications (up to 6% of BD patients) include pericarditis, endocardial lesions (aortic regurgitation and less often mitral insufficiency), myocardial lesions (myocardial infarction, myocarditis and endomyocardial fibrosis) and intracardiac thrombosis (right ventricle and atrium). Coronary lesions complicated to myocardial infarction are the most severe cardiac complications. Treatment is based on corticosteroids and immunosuppressive drugs. The use of anticoagulation in venous thrombosis is still controversial.

Citing Articles

Cardiac involvement in a female patient with Beçhet's disease: newer diagnostic and therapeutic approaches-a case report.

Kouremeti M, Kordalis A, Dimitroglou Y, Tsioufis K, Aggeli C Eur Heart J Case Rep. 2024; 8(11):ytae544.

PMID: 39525509 PMC: 11544425. DOI: 10.1093/ehjcr/ytae544.


Recurrent left main stem stenosis in a young female with Behçet's aortitis: a case report.

Dardas S, Antoun I, Sher F, Munir N, Kontoprias K Eur Heart J Case Rep. 2024; 8(7):ytae331.

PMID: 39035258 PMC: 11259188. DOI: 10.1093/ehjcr/ytae331.


A case of Behçet's disease with unusual cardiovascular complications.

Randrianarisoa R, Rakotonirina L, Ravelonjatovo M, Andrianjanaka N, Habib N, Randriamihangy N Clin Case Rep. 2023; 11(12):e8296.

PMID: 38076018 PMC: 10697831. DOI: 10.1002/ccr3.8296.


The risk of cardiovascular comorbidity in children with Behçet's disease.

Demir S, Duzova A, Karagoz T, Oguz B, Aykan H, Satirer O Rheumatology (Oxford). 2023; 63(SI2):SI188-SI194.

PMID: 37788103 PMC: 11381679. DOI: 10.1093/rheumatology/kead505.


Autoimmune Heart Disease: A Comprehensive Summary for Forensic Practice.

Mezzetti E, Costantino A, Leoni M, Pieretti R, DI Paolo M, Frati P Medicina (Kaunas). 2023; 59(8).

PMID: 37629654 PMC: 10456745. DOI: 10.3390/medicina59081364.